Meet Jennifer Harman. She is apparently one of the most famous female professional poker players in the world, having done quite well at the prestigious “World Series of Poker” tournament. It turns out she is also a kidney…
Last week’s poll results: who should provide funding for large, randomized controlled drug trials? Most respondents (58%) chose the diplomatic answer and said that it should be a combination between government and pharmaceutical companies. I was somewhat surprised…
This month’s issue of AJKD includes an enlightening group of 6 editorials, each written from a unique perspective (e.g., the perspective of large dialysis corporations, the perspective of the ESRD Networks, the perspective of non-profit dialysis corporations, etc.),…
Interestingly, there was a near 50-50 divide on last week’s poll question regarding the surprising election of Republican Scott Brown to the U.S. Senate in the state of Massachusetts. Many viewed the election as a referendum on public…
Interesting review in this month’s CJASN: “Can we personalize treatment for kidney diseases?” by Rovin et al. The term “personalized medicine” has been defined by the U.S. Congress as, “the application of genomic and molecular data to…
Scary article–from both a patient care perspective as well as from a medicolegal perspective–which will make you think about always checking that potassium level before making a decision about skipping dialysis…”Young Mother Dies After Missing Dialysis Treatment“. In…
